Nomograms predict risk for early death in HCC, may guide ‘individualized treatment’
Internally validated nomograms predicted the probability of early death and identified risk factors among patients with advanced hepatocellular carcinoma, according to research published in BMC Gastroenterology.“Studies have shown that the survival rates among patients with advanced HCC at 1, 2 and 3 years were 29%, 16% and 8%, and the median survival time was 5.3 months, indicating that advanced HCC patients were prone to early death,” Haidong Zhang, of the medical school at Southeast University in Nanjing, China, and colleagues wrote. “Therefore, early identification ofRead More